| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |